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COMPARATIVE ANALYSIS OF ALTERNATELY SPLICED PROTEIN 4.1 
mRNAs IN ERYTHROID AND NON-ERYTHROID HEMATOPOIETIC CELLS 
Jean Louise Fraser 
1991 
Protein 4.1 is a family of related protein isoforms 
generated by alternative mRNA splicing. The prototypical 
erythroid isoform is an 80 kD membrane skeleton component that 
serves to attach the cytoskeleton to the membrane through its 
binding interactions with transmembrane proteins and with 
other cytoskeletal elements. Non-erythroid isoforms, which 
localize to nuclear as well as cytoplasmic structures, differ 
from the erythroid isoform along eight nucleotide sequence 
motifs that are either inserted into or deleted from the 
primary mRNA transcript. I studied two RNA sequence motifs 
whose retention or omission affect both the size and apparent 
function of certain isoforms. The concerted splicing of these 
two motifs, IV and V, in non-erythroid cells provides a new in 
phase translation initiation site and allows manufacture of a 
135 kD isoform. This larger isoform can be produced only if 
motif IV is retained and motif V is omitted from the final 
mRNA product. Using polymerase chain reaction (PCR) 
amplification and Southern blot analysis, I studied the 
pattern of these motif IV and V splicing events in erythroid 

and non-erythroid cells. I found that the majority of 
transcripts in non-erythroid cells contain motif IV and lack 
motif V, resulting in generation of the large isoform. 
However, a minority of species encode shorter isoforms. This 
regulation of isoform production is probably accomplished via 
deletion of motif IV rather than insertion of motif V. 
In a related set of experiments, I investigated the 
timing of splicing events during red cell maturation. Motif 
I is a nucleotide sequence block that is only inserted into 
transcripts of erythrocytes. I performed RNase protection 
assays and Northern blot analyses, but these failed to detect 
the presence of motif I in mouse erythroleukemia cells; 
subsequent studies by our group demonstrated induction of 
motif I between 86 and 110 hours after treatment with dimethyl 
sulfoxide, which is at least 48 hours after induction of the 
major erythrocyte protein, globin. 
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Protein 4.1 is a family of distinct but genetically 
related phosphoprotein isoforms exhibiting differential 
expression in both a tissue-specific and developmentally 
regulated manner. The prototypical isoform is a component of 
the erythrocyte membrane cytoskeleton. 
The Erythrocyte Membrane Skeleton 
The cytoskeleton is a filamentous intracellular protein 
network that serves a structural purpose in maintaining cell 
shape and plays a functional role in effecting cell movement, 
endocytosis, and surface receptor mobility. Most eucaryotic 
cells have a radial arrangement of actin filaments, 
intermediate filaments, and microtubules to accomplish this 
end. In erythrocytes, the corresponding structure is called 
the membrane skeleton and consists only of an array of 
interlocking proteins that underlies and supports the lipid 
bilayer (Figure 1) . Red blood cells reguire an especially 
strong, yet flexible and deformable, membrane skeleton to 
withstand the shear stresses and many cell shape changes each 
undergoes during its transit through the circulation. A 
hexagonal protein lattice (Liu, 1987) periodically fixed to 





The erythrocyte membrane skeleton consists of a 
collection of large polypeptides originally identified as 
components I-VI by their relative positions on a sodium 
dodecyl sulfate polyacrylamide gel (Fairbanks, 1971). Further 
refinements of technique led to the discovery of additional 
protein species and gave rise to the now commonly used 
nomenclature for red blood cell membrane components (Steck, 
1974) (Table 1). 
Organization 
The arrangement of major proteins in the erythrocyte 
membrane is represented schematically in Figure 2. In 
general, a meshwork of long, slender spectrin molecules cross- 
linked by nodular complexes of actin, protein 4.1, and protein 
4.9 form the core of the membrane skeleton. This structure is 
then attached to the lipid bilayer via interactions with 
transmembrane proteins: ankyrin links spectrin heads to band 
3 (an anion channel), and protein 4.1 connects spectrin tails 
to glycophorin (sialoglycoproteins bearing blood group 
antigens). 
Role of Protein 4.1 
Protein 4.1 participates in several of the key 
interactions of membrane skeleton components. The binding of 
protein 4.1 to spectrin greatly amplifies, strengthens, and 
stabilizes the association of spectrin tetramers and F-actin 
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1 240 a-Spectrin 
P 27 200,000 
1q22-q25 
2 220 /ff-Spectrin 14 
2.1 210 




- 103 Adducin P 1 30,000 
; 97 
3 100 Anion Channel I 30 1,100,000 17 
4.1 80/78 P 5 200,000 1p36.2-p34 
4.2 72 P 5 250,000 
4.9 48 P 0.5 30,000 





P 5 500,000 
7 29/27 Erythrocyte Tropomyosin P 4 500,000 
8 23 P 1-2 200,000 
GPA 31 Glycophorin A I 1.6 500,000 4q28-q31 
GPB 23 Glycophorin B I 0.3 100,000 4q28-q31 
GPC 28 Glycophorin C I 0.1 50,000 2q14-q21 
Adapted from Lux, S.E., and Becker, P.S. Disorders of the Red 
Cell Membrane Skeleton. In The Metabolic Basis of Inherited 
Disease, 6th ed. , Scriver, C.R., Beaudet, A.L., Sly, W.S., and 




(Ungewickell, 1979) . This ternary complex imparts the 
necessary degree of rigidity to the cell membrane. Protein 
4.1 also binds to the cytoplasmic domain of glycophorin 
(Anderson, 1984) in the presence of a specific 
polyphosphoinositide cofactor (Anderson, 1985). This 
interaction constitutes one class of attachment mechanisms for 
securing the cytoskeleton to the cell membrane. Finally, it 
has been observed that protein 4.1 can associate with band 3 
as well (Pasternack, 1985) . The use of this second, lower 
affinity transmembrane binding site may be related to the 
availability of phosphorylated metabolites. 
Protein 4.1 in Abnormal Erythrocytes 
The finding of quantitative or qualitative defects of 
protein 4.1 in clinically atypical erythrocytes confirms the 
role of this membrane skeleton constituent as a major 
determinant of red cell shape and durability. Studies of 
families with the condition hereditary elliptocytosis (HE) 
show that a subset of cases within this heterogeneous disorder 
are due to reduced levels of protein 4.1 (Tchernia, 1981). In 
the heterozygous form, a 50% decrease of protein 4.1 results 
in smooth, well-elongated elliptocytes with normal osmotic 
fragility. Clinically, little or no hemolysis occurs 
(Alloisio, 1985). Homozygotes, who are completely lacking 
protein 4.1, have a severe, transfusion-dependent hemolytic 
anemia with marked elliptocytosis and cell fragmentation 
(Tchernia, 1981). Normal mechanical stability can be restored 
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by addition of purified protein 4.1 to deficient cells 
(Takakuwa, 1986). 
Another subset of HE cases can also be attributed to a 
protein 4.1 defect, despite the presence of normal protein 4.1 
levels. Biochemical analysis of protein 4.1 polypeptides 
(Marchesi, 1990) and molecular analysis of mRNA transcripts 
(Conboy, 1990) reveals that insertion and deletion mutations 
produce structural variants of protein 4.1. The variants 
characterized to date have alterations in the spectrin-actin 
binding domain (see "Structural Model of Protein 4.1"). 
Deletion of the entire domain results in erythrocytes with 
markedly decreased mechanical stability, fragmented cells in 
the circulation, and a moderately severe hemolytic anemia. 
Duplication of the domain leads to only mild elliptocytosis 
without anemia. 
Analogues of Protein 4.1 in Non-Erythroid Cells 
Proteins immunologically cross-reactive with erythroid 
protein 4.1 are present in a wide variety of cell types. 
These species appear to function generally as linking 
molecules, although an exact parallel with the erythroid 
version is not uniformly applicable. In granulocytes 
(Spiegel, 1984) and platelets (Davies, 1985), the analogue is 
associated with the cytoskeleton, while in lymphoid cells 
(Spiegel, 1986) it is found in the cytoplasm. None of these 
proteins bind spectrin. An isoform in bovine aortic 
endothelial cells localizes to the cortical membrane, the 
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perinuclear region, and areas of cell-cell contact (Leto, 
1986) ; the counterpart in fibroblasts is distributed evenly 
along stress fibers (Cohen, 1982). Protein 4.1-like proteins 
in these cells may serve to integrate actin filaments and 
other actin-binding skeletal components. The bovine lens also 
contains analogous forms which bind the lens version of 
spectrin and may play a role in the coupling of lens 
cytoskeleton to the plasma membrane. 
The analogue of protein 4.1 immunologically isolated from 
neuronal cells is identical to a previously described protein 
named synapsin I (Baines, 1985) . It has the same location as 
brain spectrin in the cortical cytoplasm (Goodman, 1984) , and 
also binds to microtubules (Baines, 1986). Synapsin I is a 
known component of synaptic vesicles and is felt to have a 
linking function in joining vesicles to the plasma membrane or 
in attaching them to the axonal transport system. 
Analogues of Protein 4.1 in Avian Erythrocytes 
From extensive investigation of the avian erythrocyte 
system, a model of protein 4.1 expression has been developed 
which may provide interesting clues for analysis of the human 
system. The nucleated red cells of chickens contain several 
polypeptide variants, ranging in size from 77 kD to 17 5 kD 
(Granger, 1984) . These isoforms are expressed in a 
developmentally regulated manner (Granger, 1985), with a 
transition from one set of forms predominately found in 
immature erythroblasts to another set of forms occurring 
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largely in mature erythrocytes (Yew, 1987) . The finding of a 
single protein 4.1 gene that gives rise to numerous 6.6 kb 
mRNAs by differential RNA processing, provides a likely 
mechanism for the generation of these multiple, stage- 
dependent protein 4.1 variants (Ngai, 1987). 
Structural Model of Protein 4.1 
The prototypical erythroid protein 4.1 is actually a 
combination of two sequence-related phosphoproteins, 
designated 4.1a (80 kD) and 4.1b (78 kD) (Goodman, 1982). 
Limited proteolysis and specific chemical cleavage methods 
have enabled a detailed structural characterization of this 
protein (Leto, 1984) (Figure 3). 
The 30 kD amino terminal domain is highly basic and 
resistant to further proteolytic digestion. Sites involved in 
binding protein 4.1 to cytoplasmic domains of the 
transmembrane proteins glycophorin and band 3 are located here 
(Leto, 1984). Sequence analysis shows this region to be 
hydrophobic and rich in beta-sheet structure. In addition, 
the 30 kD domain contains all seven cysteine residues and all 
three potential glycosylation sites present in the protein. 
These characteristics suggest a tightly compacted tertiary 
structure (Conboy, 1986a). 
The 16 kD second domain (Leto, 1984) is hydrophilic and 
contains sites for phosphorylation by protein kinase C and 
cAMP-dependent kinase (Conboy, 1986a). This region has no 
known binding function and may simply act as a linker between 
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the membrane-glycophorin binding domain and the spectrin-actin 
binding domain. 
The 10 kD third domain (Leto, 1984) is responsible for 
the binding of protein 4.1 to spectrin-actin complexes 
(Correas, 1986). It is highly charged and the secondary 
structure contains a relatively long alpha-helix. A site for 
cAMP-dependent kinase phosphorylation is also present (Conboy, 
1986a). 
The 22-24 kD carboxyl terminal domain is highly acidic 
and protease sensitive. The difference between the closely 
related proteins 4.1a and 4.1b lies in the post-translational 
modification of this domain (Leto, 1984). 
Expression of the Protein 4.1 Gene 
No cis- or trans-acting factors that influence 
transcription of the protein 4.1 gene have been identified. 
It is known that the synthesis of red cell membrane proteins 
is asynchronous during erythropoiesis and that protein 4.1 is 
among the last still being synthesized by reticulocytes 
(Chang, 1976). The relationship between expression of various 
components and assembly of the membrane skeleton is currently 
a topic of considerable interest. How the timing of 
expression of individual proteins might direct assembly of the 
cytoskeleton is uncertain. 
Molecular Basis of Protein 4.1 Diversity 
Cloning and sequencing of protein 4.1 cDNA (DNA 
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synthesized in vitro that is complementary to mRNA) has 
revealed that protein 4.1 is not a single entity but a 
heterogeneous family of related protein isoforms (Tang, 
1988b). The isoforms are generated by alternative mRNA 
splicing of a common precursor and differ from one another at 
several specific sites. These nucleotide sequence segments, 
designated motifs I-VIII (Figure 4), are inserted or deleted 
en bloc and result in the production of numerous, distinct 
mRNAs. It now appears that multiple splicing pathways are 
operative even within a single cell type (Conboy, 1988) , which 
then give rise to functionally divergent proteins. Aberrant 
splicing can lead to the manufacture of defective protein 4.1 
species and to the clinical manifestations of HE described 
earlier (Conboy, 1986b). 
Motif I encodes a 21 amino acid segment within the 
spectrin-actin binding domain. It is found in the protein 4.1 
made by erythrocytes but not in that of lymphoid cells (Tang, 
1988b). The ability of erythroid protein 4.1 to bind 
erythroid spectrin depends on the presence of the peptide 
piece determined by motif I (Horne, in press). Moreover, 
insertion of motif I is an inducible splicing event triggered 
during red cell maturation (L. Lou, unpublished data). Thus, 
motif I expression is governed by a tissue-specific and 
developmentally regulated splicing pathway. 
Motifs II, III, VI, VII, and VIII are present in the vast 
majority of transcripts from both erythroid and non-erythroid 
cells (E. Benz, unpublished observations). Isoforms lacking 

10 
any of these motifs comprise only a fraction of the protein 
4.1 in a given cell type, and the functional significance of 
these variants is unknown. 
A Nuclear Protein 4.1 Isoform 
Motifs IV and V are located 5' to the region of mRNA that 
is translated into the 80 kD protein 4.1 prototype by 
erythroid cells (Figure 4). Motif IV contains a new site for 
translation initiation, and motif V contains in phase stop 
codons. Two concerted splicing events, resulting in insertion 
of motif IV and deletion of motif V, place the new start site 
within a contiguous open reading frame that is in the same 
phase as the 80 kd protein (Tang; 1988a, 1990). Use of this 
upstream initiation codon allows synthesis of a larger 135 kD 
protein 4.1 isoform whose terminal 80 kD is identical to the 
prototypical erythroid isoform (Tang, 1990). When both start 
sites are present, the upstream codon is preferentially 
utilized (Tang; 1988a, 1990). 
The high molecular weight variant of protein 4.1 includes 
an additional 209 amino acid polypeptide, corresponding to a 
calculated molecular weight of 27 kD, which is connected to 
the amino terminal end of the 30 kD domain of the erythroid 
protein 4.1 isoform. This headpiece is hydrophilic, contains 
three cysteine residues, and is rich in alpha-helical 
secondary structure (Tang, 1988a). Antibodies directed 
against the headpiece localize the 135 kD protein 4.1 isoform 
to the nuclei, as well as the cytoplasm, of non-erythroid 
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cells (Tang, in press). Current working hypotheses postulate 
a role for this nuclear isoform in linking the nuclear 
membrane to its skeleton or in integrating components of a 
nuclear scaffolding apparatus. 
Thesis Goals 
Recent studies (c.f. preceding sections) indicate that a 
single protein 4.1 gene gives rise to a family of protein 4.1 
isoforms, some of which display tissue-specific expression. 
Regulation of isoform production appears to be at the level of 
mRNA splicing. Further understanding of isoform generation 
will require investigation of the mechanisms governing this 
splicing. However, it will first be necessary to characterize 
the patterns of motif expression in different tissues, with 
special attention to erythroid tissue, since tissue- 
specificity has already been demonstrated in mature red cells. 
Specific questions to be addressed include: Which motifs are 
developmentally induced or repressed, meaning spliced in or 
out in response to a given stimulus? Are motifs subject to 
individually regulated events or to concerted splicing, i.e. 
the splicing of one always accompanies splicing of the other? 
What is the timing of these splicing events during 
differentiation? An important focus will be the examination 
of the complex splicing events required for generation of the 
high molecular weight isoform. Production of this isoform is 
repressed during erythroid maturation but co-exists with 
production of low molecular weight variants in most other 
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tissues. For these reasons I chose to concentrate my initial 
efforts on analysis of motifs IV and V, as it is their 
splicing that determines which isoform, i.e. large or small, 
is manufactured. 
The aim of this work was to investigate the expression of 
motifs IV and V in erythroid and non-erythroid cells. 
Nucleated cells produce both low and high molecular weight 
versions of protein 4.1. The splicing events required to 
generate the larger variant have been described; however, the 
smaller variant can result via a number of possible pathways: 
(1) deletion of motif IV, thereby removing the upstream 
initiation site; (2) insertion of motif V, which places stop 
codons in phase with the upstream start site and causes 
premature termination of translation; or (3) both deletion of 
motif IV and insertion of motif V. The research presented 
here examines the operative mechanism in elimination of the 
high molecular weight protein 4.1 isoform by non-erythroid, 
i.e. nucleated, cells. 
Erythroid cells provide another setting in which to study 
the expression of motifs IV and V. During maturation from 
erythroblast to erythrocyte, the nuclei of these cells become 
pyknotic and are extruded. It is expected that production of 
the nuclear isoform of protein 4.1 will mirror this process. 
Accordingly, an inducible splicing event, such as that of 
motif I insertion, may also be governing expression of motif 
IV or V, or both. To that end, this research also examines 
the pattern of splicing of motifs IV and V during maturation 

of an erythroid cell line. 
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Figure Is The erythrocyte membrane skeleton contrasted with 






Figure 2: The erythrocyte membrane skeleton. Spectrin dimers 
composed of intertwined a- and /^-chains self-associate at one 
end to form tetramers or higher oligomers (B) and bind to 
short filaments of F-actin and protein 4.1 at the opposite end 
(D). The membrane skeleton is attached to the lipid bilayer 
via interactions with ankyrin to the transmembrane protein 
band 3 (A) and with protein 4.1 to the transmembrane protein 
glycophorin (C) or protein 3. Tropomyosin (T) lies in the 
groove of the actin protofilament. (From Becker, P.S., and 
Benz, E.J. , Jr. Molecular Biology of the Red Blood Cell 
Membrane Proteins. In Molecular Biology of the Cardiovascular 
System, Chien, S. editor. Copyright Lea and Febiger, 




Figure 3: Structural model of protein 4.1. 
A. The four domains of the protein 4.1 molecule identified by 
limited chymotryptic cleavage are diagrammed. Potential 
glycosylation sites are indicated by "G"; potential 
phosphorylation sites are indicated by "P"; "SH" denotes 
cysteine residues. 
B. Secondary structural features of protein 4.1. Symbols are 
as follows: 






- - - -, random turns and coils. 





Figure 4: Protein 4.1 isoforms. 
A. Structural model of human erythroid protein 4.1. The four 
segments (30 kD, 16 kD, 10 kD, 22/24 kD) represent the 
molecular weights of the four fragments ("domains") generated 
by limited chymotryptic digestion. B. Location of motifs I - 
VIII. C. Two open reading frames (ORF 1 and 2) are found in 
the mRNA transcript. D. Region of mRNA translated to 
generate erythroid protein 4.1. E. Region of mRNA translated 
to generate non-erythroid 135 kD protein 4.1 isoform. 
A. N 






























Erythroid protein 4.1 prototype 
3' UT 
E. Met 
- Non-erythroid 135 kD protein 4.1 isoform 

18 
MATERIALS and METHODS 
Cell Culture. Several human non-erythroid hematopoietic cell 
lines were studied. Previous work in this laboratory has 
shown that the available human erythroid cell lines do not 
differentiate completely enough to generate the erythroid 
isoforms of protein 4.1. Therefore, I focused my studies of 
erythroid isoforms on the mouse erythroleukemia (MEL) cell 
line. MEL cells are a permanent cell line from mice with a 
virally induced erythroleukemia. In the constitutive state, 
the cells are arrested at or near the proerythroblast stage of 
maturation. Upon exposure to any one of several inducing 
compounds (dimethyl sulfoxide, butyric acid, hexamethylene, 
bis-acetamide, etc.), the cells undergo erythroid maturation. 
The induced cells exhibit commitment to terminal maturation, 
as evidenced by de novo expression of numerous phenotypic 
markers of developing red cells (e.g. hemoglobin, erythroid 
spectrin, heme synthetic enzymes, etc.). These cells are the 
most thoroughly studied in vitro model of erythroid 
differentiation (Marks, 1978). 
MEL cells were maintained in Dulbecco's modified Eagle's 
medium (DMEM) containing 10% fetal calf serum, 100 U/ml 
penicillin, 100 /xg/ml streptomycin, and 2 mM L-glutamine. 
Induced cells were treated with 1.8% dimethyl sulfoxide (DMSO) 
and harvested 12 hr, 24 hr, and 48 hr after induction. 
Uninduced cell samples were also collected at each of the 
above time points to serve as controls. 
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My analysis of nonerythroid isoforms, especially the 
large isoform, focused on the following lymphoid and myeloid 
cell lines, which were known to produce the 135 kD isoform. 
These included HL60 (granulocytic/monocytic), KG-1 and KG-la 
(monocytic) , MOLT 4 (T-cell) , CCRF-CEM and HUT 78 (B-cell) . 
Cell lines were maintained in RPMI 1640 medium supplemented 
with 2 mM L-glutamine, 100 U/ml of penicillin, 100 jug/ml of 
streptomycin, and 10% fetal calf serum at 37°C in a 5% C02 
atmosphere. 
Total RNA Isolation. Total RNA from cultured cell lines was 
prepared in the presence of guanidine isothiocyanate (Davis, 
1986) . The cells (5 x 107) were pelleted by centrifugation at 
2500 rpm in a HS-4 rotor for 5 minutes and resuspended in 8 ml 
of GIT buffer (4 M guanidine isothiocyanate / 25 mM sodium 
citrate / 7% /?-mercaptoethanol) . The GIT buffer lyses the 
cells, releasing nucleic acids, denaturing proteins, and 
increasing the viscosity of the solution. 
The GIT-solubilized cells were layered onto 4 ml of CsCl 
buffer (5.7 M CsCl / 25 mM sodium acetate) and centrifuged at 
32,000 rpm in a SW41 rotor for 18 hrs at 20°C. The clear 
gelatin-like RNA pellet at the bottom of the tube was 
collected and resuspended in 200 /il diethyl pyrocarbonate 
(DEPC) treated water. The RNA was further purified by 
extraction with saturated phenol/chloroform and precipitation 
with ethanol. The RNA was then recovered by centrifugation 
and dissolved in DEPC water. 
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Synthesis of High Specific Activity RNA Probes. Transcription 
plasmids containing cDNA inserts of interest and the T7 
promoter were kindly provided by Dr. Tang K. Tang. Antisense 
RNA probes spanning motif I were generated by using T7 RNA 
polymerase. The following components were mixed in the order 
given in a 1.5 ml tube: 2.5 jul DEPC water, 4 jul 5X 
transcription buffer (200 mM Tris-HCl, pH 7.5 / 30 mM MgCl2 / 
10 mM spermidine / 50 mM NaCl) , 2 jLtl 100 mM dithiothreitol, 40 
U RNasin ribonuclease inhibitor, 4 jLtl rNTP (2.5 mM ATP / 2.5 
mM GTP / 2.5 mM UTP) , 2.4 jLtl 100 mM CTP, 1 jLtl containing 0.2-1 
jitg linearized DNA template, 5 jLtl a32P-CTP (50 jLtCi) , and 1 U T7 
RNA polymerase. Incubation proceeded at 37°C for 60 minutes. 
Following the RNA synthesis reaction, RNase free-DNase 
was added to a concentration of 1 U/jLtg DNA. Incubation was 
continued at 37°C for 15 minutes. The reaction mixture was 
extracted with an equal volume of phenol/chloroform. RNA was 
then recovered by precipitation with ethanol. 
RNase Protection Assay. RNase protection analysis was 
performed using the uniformly labeled antisense RNA probes. 
Total RNA was hybridized to the antisense probe, followed by 
digestion with RNase A and Tl. 
Dried RNA samples (40 jug) were dissolved in 30 jul of 
formamide hybridization buffer (80% formamide / 40 mM PIPES, 
pH 6.5 / 0.4 M NaCl / 1 mM EDTA) containing antisense probe (5 
x 105 cpm) ,heated at 85°C for 5 minutes, and then incubated at 
4 5°C overnight. Following hybridization, 300 /il of RNase 
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digestion buffer (10 mM Tris-HCl, pH 7.5 / 5 mM EDTA / 300 mM 
NaCl) containing 40 /xg of RNase A and 2 /zg of RNase T1 was 
added. RNase digestion was allowed to proceed at 30°C for 1 
hr. 
The reaction was stopped by the addition of 20 ill of 10% 
SDS and 50 /zg proteinase K, followed by incubation at 37°C for 
15 minutes. Samples were phenol extracted, ethanol 
precipitated, dried, and dissolved in loading buffer (80% 
formamide, 0.025% bromophenol blue). The protected products 
were denatured for 3 minutes at 90°C and analyzed on a 
denaturing polyacrylamide / 8 M urea gel. 
Poly (A) + RNA Isolation. Poly (A) + RNA was selected by 
hybridization to messenger affinity paper (mAP). 200 /xg of 
total RNA was dissolved in 100 /zl 0.5 M NaCl and spotted onto 
a 1 cm2 piece of mAP. The mAP was then washed three times in 
0.5 M NaCl and once in 70% ethanol. It was next blotted on 
filter paper and allowed to dry. The poly (A)+ RNA was eluted 
with 3 0 /zl DEPC water in a 70°C water bath for 5 minutes. 
End Labeling of Synthetic Oligonucleotide Probes. Synthetic 
oligonucleotides complementary to portions of motif I, motif 
IV, and motif V (Figure 5) were chemically synthesized and gel 
purified by Ms. Monica Talnor, Department of Pathology. These 
probes were labeled on the 5' ends using polynucleotide kinase 
(Davis, 1986). 0.25 /xg of synthetic oligonucleotide was 
incubated with 15 U of T4 polynucleotide kinase and 2 0 ill of 
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K32P-ATP (200 11Ci) in kinase buffer (50 mM Tris-HCl, pH 7.5 / 
10 mM MgCl2 / 5 mM dithiothreitol / 0.1 mM spermidine / 0.1 mM 
EDTA) for 1 hr at 37°C. 
Removal of unincorporated nucleotides from the labeled 
DNA was accomplished by passing samples through activated Sep- 
Pak C18 cartridges. Columns were prewetted with 3 ml of 25% 
acetonitrile and 10 ml of distilled water. After application, 
the oligonucleotides were eluted with two separate 0.8 ml 
aliquots of 25% and 50% acetonitrile and then lyophilized. 
Probes were then resuspended in 200 /il of water; 1 jul was 
counted in a scintillation counter to determine the activity 
of the probes. 
Northern (RNA) Blot Analysis. Poly (A)+ RNA was fractionated 
by electrophoresis through a 1.4% agarose formaldehyde gel (20 
mM MOPS buffer, pH 7.0 / 5 mM sodium acetate / 0.5 mM EDTA / 
2.2 M formaldehyde). The running buffer for the system was 
equivalent to the gel buffer without formaldehyde. 
Following electrophoresis, the poly (A) + RNA was 
transferred to Nytran filters and hybridized with the end 
labeled synthetic oligonucleotide probes. After baking the 
filters for 2 hr under vacuum at 80°C, prehybridization was 
performed in 6.7X SCP (IX SCP is 0.03 M NaP04, pH 6.5 / 0.1 M 
NaCl / 1 mM EDTA) / 10X Denhardt' s solution (IX Denhardt' s 
solution is 0.02% Ficoll 400 / 0.02% polyvinylpyrrolidone / 
0.02% bovine serum albumin) / 1% sarkosyl / 1 /xg/ml denatured 
salmon sperm DNA at 45°C for 1-2 hrs. The hybridization 
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solution contained the radiolabeled probe, carrier DNA (20 
lug/ml final concentration), and 6.7X SCP / 10X Denhardt's 
solution / 1% sarkosyl / 10% dextran sulfate. The filters 
were incubated overnight at 45°C and then washed in 500 ml of 
6.7X SCP / 0.5% sarkosyl, once at room temperature and three 
times at 45°C. After washing, the filters were baked and 
autoradiographed for up to 72 hrs. 
Generation of cDNA from mRNA. Total RNA from the following 
cells was kindly provided by Dr. Lily Lou. Non-erythroid lines 
included HL60 (granulocytic/monocytic), KG-1 and KG-la 
(monocytic) , MOLT 4 (T-cell) , CCRF-CEM and HUT 78 (B-cell) ; 
RNA from the erythroid MEL cell line had also been collected 
at 0, 27, 48, 60, 73, 86, 98, 110, 122, 167, and 186 hours 
after induction with DMSO. To prepare cDNA, 5 jLtg of total RNA 
was transcribed into single-stranded DNA at 42°C for 2 hrs in 
a 20 /il reaction containing 40 mM KC1 / 50 mM Tris-HCl, pH 8.5 
/ 8 itiM MgC12 / 0.5 mM each dNTP / either 2 jug oligo dT primer, 
4 fig dN6 random hexamer primer, or 150 pmol specific antisense 
oligonucleotide / 10 U AMV reverse transcriptase / 40 U 
RNasin. Several primer strategies were attempted; the data 
presented in "Results" was obtained with oligo dT primer. 
Primer Synthesis and Purification. Oligonucleotide primers 
for use in polymerase chain reaction (PCR) amplifications 
(Figure 6) were chemically synthesized by Ms. Monica Talnor, 
Department of Pathology (motifs I and V), and Dr. John Flory, 
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Department of Human Genetics (motif IV). Primers received in 
an unpurified form were passed through an activated Sep-Pak 
C18 cartridge as described in a previous section (see "End 
Labeling of Synthetic Oligonucleotide Probes"). 
FOR Amplification of Motifs I, IV, and V. Amplification of 
motif I in MEL cells was performed by Dr. Lily Lou. The PCR 
amplification of motifs IV and V in non-erythroid and MEL 
cells contained 2 /x 1 cDNA / 10 pmol sense-strand primer / 10 
pmol antisense-strand primer / 0.2 mM each dNTP / 2.5 U Tag 
polymerase in PCR buffer (10 mM Tris-HCl, pH 8.5 / 50 mM KC1 
/ 1.5 mM MgCl2 / 0.1% gelatin). Thirty cycles of 
amplification were performed using an automated Perkin-Elmer 
Cetus thermal cycler under the following conditions: melting, 
1.5 min at 94°C; annealing, 2 min at 55°C; polymerizing, 3 min 
at 72°C. 
Southern (DNA) Blot Analysis. PCR products were analyzed by 
2% agarose gel electrophoresis in TBE buffer (50 mM Tris-HCl, 
pH 7.5 / 50 mM boric acid / 1 mM EDTA) . After 
electrophoresis, gels were washed in 200 ml of denaturing 
solution (1.5 M NaCl / 0.5 N NaOH) followed by 200 ml of 
neutralizing solution (1.5 M NaCl / 0.5 M Tris-HCl, pH 7.5) 
for 1 hr each. DNA fragments were then transferred to 
nitrocellulose filters and hybridized with end labeled 
synthetic oligonucleotide probes to the motif of interest. 
Conditions for oligonucleotide hybridization and washing were 
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as previously described (see "Northern Blot Analysis") with 
slight modifications. Baked filters were prehybridized in 6X 
SSC (IX SSC is 0.15 M NaCl / 15 mM Na citrate) / 5X Denhardt' s 
solution / 0.5% SDS / 1% denatured salmon sperm DNA at room 
temperature for 3 hrs. The hybridization solution was 
identical to the prehybridization buffer with addition of 0.01 
M EDTA and the radiolabeled probe. Hybridization proceeded 
overnight at 31°C for motif IV and at 53°C for motif V. The 
filters were then washed four times: 5 min in 2X SSC / 0.5% 
SDS, 15 min in 2X SSC / 0.1% SDS, 15 min in 0.4X SSC / 0.1% 
SDS, and 15 min in 0.1X SSC / 0.1% SDS. After washing, the 




Figure 5: Synthetic oligonucleotide probes used to identify 
motifs I, IV, and V in Northern and Southern blot analyses. 
A. Motif I. B. Motif IV and motif V. 
A 
1 TGGCCCAAAG TGCTGAAGAT TTCTTATAAA CGTAGTAGCT TTTTCATCAA GATTCGGCCT 
61 GGAGAGCAAG AGCAGTATGA AAGTACCATC GGATTCAAAC TTCCCAGTTA CCGAGCAGCT 
121 AAGAAATTAT GGAAAGTCTG TGTAGAACAT CACACGTTTT TCAGATTGAC ATCTACAGAC 
181 ACCATTCCCA AAAGCAAATT TCTTGCGCTA GGATCCAAAT TTCGATACAG TGGCCGGACT 
241 CAAGCTCAGA CCAGGCAAGC TAGTGCTCTA ATTGACAGGC CTGCCCCACA CTTCGAGCGT 
301 ACAGCAAGTA AACGGGCGTC CCGGAGCCTC GATGGAGCAG CAGCTGTCGA TTCGGCAGAC 
361 CGAAGTCCTC GGCCCACTTC TGCACCTGCC ATTACTCAGG GTCAGGTTGC AGAAGGTGGC 
421 GTCCTAGATG CCTCTGCTAA AAAAACAGTG GTCCCTAAAG CACAGAAGGA AACAGTGAAG 
481 GCTGAAGTGA AAAAGGAAGA CGAGCCACCT GAGCAAGCTG AGCCAGAGCC CACAGAAGCA 
Motif I 
541 TGGAAGAAAA AGAGAGAAAG jj a j* § GAAAACATTT ATATCAGACA TAGCAATTTA 
T TCTCTCTTTC TGATCTACCA CTTTTGTAAA TATAGTCTG 
601 ATGTTGGAGG ATTTAGACAA GAGTCAAGAG GAGATCAAAA AACATCATGC CAGCATCAGT 
661 GAGCTGAAAA AGAACTTCAT GGAGTCTGTA CCAGAACCAC GGCCTAGTGA ATGGGATAAA 
721 CGCTTATCCA CTCACTCACC CTTCCGAACT CTTAACATCA ATGGGCAAAT CCCCACAGGA 
781 GAAGGACCTC CCCTGGTGAA GACACAAACT GTCACCATCT CAGATAATGC CAATGCTGTG 
841 AAAAGTGAAA TCCCAACCAA AGACGTCCCT ATTGTCCACA CTGAGACCAA GACCATCACT 





TCCCGTGGAG CAGAGGGGCA AAGTGGCAGG AACCTCTTAA AGGGCGAGAG CGGCGCGGAG 
Motif IV 
CCAGAACGCG GTCGGCCCGG TCCCCGCCGC ACCCAGCCCA GG^GAll^AT GACAAGAGAG 
GTTGTAGTA CTGTTGTC 
121 AAGAGTTTAG TGACTGAGGC CGAAAATTCA CAGCACCAAC AGAAGGAAGA GGGTGAGGAA 
181 GCCATAAACT CAGGCCAACA AGAACCTCAG CAGGAGGAAT CTTGTCAAAC AGCAGCTGAA 
241 GGAGATAATT GGTGTGAACA GAAGCTGAAA GCTTCTAATG GAGACACTCC TACACATGAA 
301 GACTTGACCA AGAACAAGGA GCGGACATCA GAAAGCAGAG GACTTTCACG ACTATTCTCC 
361 TCGTTTCTCA AAAGGCCCAA ATCTCAGGTG TCCGAGGAAG AAGGCAAAGA AGTAGAGTCA 
421 GATAAAGAAA AAGGTGAAGG AGGTCAGAAA GAGATAGAAT TTGGAACCAG TCTTGATGAA 
481 GAGATCATTT TAAAGGCCCC AATTGCAGCT CCTGAACCGG AACTCAAAAC AGACCCATCT 
541 TTGGATCTTC ATTCATTAAG CAGTGCAGAA ACACAGCGTG ACCATTACAA TTAAGAATTA 
TAAT 
Motif V 
601 TTTTTAGAGT CTTCTTATTT CTGAAGCATG TGAATATTAT; CTCGATCGTT AAAAGTCCTG 
AAAAATCTCA GAAGAATAAA GACTTCGTAC ACTTATAATA GAGCTAGCAA 
661 CTCAGGAAGA ACTCAGAGAA GATCCAGATT TTGAAATTAA GGAAGGAGAA GGACTTGAAG 
721 AGTGCTCCAA AATAGAAGTA AAAGAAGAAA GCCCTCAATC AAAAGCAGAA ACAGAATTAA 
781 AAGCTTCCCA AAAACCAATC AGAAAACACA GGAACATGCA CTGCAAGGTT TCTTTGTTGG 




Figure 6: Synthetic oligonucleotide primers used 
amplification of motifs I, IV, and V. A. Motif I. B 




1 TGGCCCAAAG TGCTGAAGAT TTCTTATAAA CGTAGTAGCT TTTTCATCAA GATTCGGCCT 
ACCGGGTTTC ACGACTTCTA AAGAATATTT GCATCATCGA AAAAGTAGTT CTAAGCCGGA 
61 GGAGAGCAAG AGCAGTATGA AAGTACCATC GGATTCAAAC TTCCCAGTTA CCGAGCAGCT 
CCTCTCGTTC TCGTCATACT TTCATGGTAG CCTAAGTTTG AAGGGTCAAT GGCTCGTCGA 
121 AAGAAATTAT GGAAAGTCTG TGTAGAACAT CACACGTTTT TCAGATTGAC ATCTACAGAC 
TTCTTTAATA CCTTTCAGAC ACATCTTGTA GTGTGCAAAA AGTCTAACTG TAGATGTCTG 
181 ACCATTCCCA AAAGCAAATT TCTTGCGCTA GGATCCAAAT TTCGATACAG TGGCCGGACT 
TGGTAAGGGT TTTCGTTTAA AGAACGCGAT CCTAGGTTTA AAGCTATGTC ACCGGCCTGA 
241 CAAGCTCAGA CCAGGCAAGC TAGTGCTCTA ATTGACAGGC CTGCCCCACA CTTCGAGCGT 
GTTCGAGTCT GGTCCGTTCG ATCACGAGAT TAACTGTCCG GACGGGGTGT GAAGCTCGCA 
301 ACAGCAAGTA AACGGGCGTC CCGGAGCCTC GATGGAGCAG 
TGTCGTTCAT TTGCCCGCAG GGCCTCGGAG CTACCTCGTC 
CAGCTGTCGA TTCGGCAGAC 
GTCGACAGCT AAGCCGTCTG 
361 CGAAGTCCTC GGCCC ?YCTTC 
GCTTCAGGAG CCGGGTGAAG 
TGCACCTGCC ATTACTCAGG GTCAGGTTGC AGAAGGTGGC 
ACGTGGACGG TAATGAGTCC CAGTCCAACG TCTTCCACCG 
421 GTCCTAGATG CCTCTGCTAA AAAAACAGTG GTCCCTAAAG 
CAGGATCTAC GGAGACGATT TTTTTGTCAC CAGGGATTTC 
CACAGAAGGA AACAGTGAAG 
GTGTCTTCCT TTGTCACTTC 
481 GCTGAAGTGA AAAAGGAAGA CGAGCCACCT GAGCAAGCTG AGCCAGAGCC CACAGAAGCA 
CGACTTCACT TTTTCCTTCT GCTCGGTGGA CTCGTTCGAC TCGGTCTCGG GTGTCTTCGT 
Motif I 
541 TGGAAGAAAA AGAGAGAAAG ACTAGATGGT GAAAACATTT ATATCAGACA TAGCAATTTA 
ACCTTCTTTT TCTCTCTTTC TGATCTACCA CTTTTGTAAA TATAGTCTGT ATCGTTAAAT 
601 ATGTTGGAGG ATTTAGACAA GAGTCAAGAG GAGATCAAAA AACATCATGC CAGCATCAGT 
TACAACCTCC TAAATCTGTT CTCAGTTCTC CTCTAGTTTT TTGTAGTACG GTCGTAGTCA 
661 GAGCTGAAAA AGAACTTCAT GGAGTCTGTA CCAGAACCAC GGCCTAGTGA ATGGGATAAA 
CTCGACTTTT TCTTGAAGTA CCTCAGACAT GGTCTTGGTG CCGGATCACT TACCCTATTT 
721 CGCTTATCCA CTCACTCACC CTTCCGAACT CTTAACATCA ATGGGCAAAT CCCCACAGGA 
GCGAATAGGT GAGTGAGTGG GAAGGCTTGA [GAATTGTAGT TACCCGTTTA GGGGTGTCCT 
781 GAAGGACCTC CCCTGGTGAA GACACAAACT GTCACCATCT CAGATAATGC CAATGCTGTG 
CTTCCTGGAG GGGACCACTT CTGTGTTTGA CAGTGGTAGA GTCTATTACG GTTACGACAC 
841 AAAAGTGAAA TCCCAACCAA AGACGTCCCT ATTGTCCACA CTGAGACCAA GACCATCACT 
TTTTCACTTT AGGGTTGGTT TCTGCAGGGA TAACAGGTGT GACTCTGGTT CTGGTAGTGA 




1 TCCCGTGGAG CAGAGGGGCA AAGTGGCAGG AACCTCTTAA AGGGCGAGAG CGGCGCGGAG 
AGGGCACCTC GTCTCCCCGT TTCACCGTCC TTGGAGAATT TCCCGCTCTC GCCGCGCCTC 
_ Motif IV 
61 CCjAGAACGCG GTCGGCCCG|G TCCCCGCCGC ACCCAGCCCA GCAACATCAT GACAACAGAG 
GGTCTTGCGC CAGCCGGGCC AGGGGCGGCG TGGGTCGGGT CGTTGTAGTA CTGTTGTCjTC 
121 AAGAGTTTAG TGACTGAGGC CGAAAATTCA CAGCACCAAC 





181 GCCATAAACT CAGGCCAACA AGAACCTCAG CAGGAGGAAT CTTGTCAAAC AGCAGCTGAA 
CGGTATTTGA GTCCGGTTGT TCTTGGAGTC GTCCTCCTTA GAACAGTTTG TCGTCGACTT 
241 GGAGATAATT GGTGTGAACA GAAGCTGAAA GCTTCTAATG GAGACACTCC TACACATGAA 
CCTCTATTAA CCACACTTGT CTTCGACTTT CGAAGATTAC CTCTGTGAGG ATGTGTACTT 
301 GACTTGACCA AGAACAAGGA GCGGACATCA GAAAGCAGAG GACTTTCACG ACTATTCTCC 
CTGAACTGGT TCTTGTTCCT CGCCTGTAGT CTTTCGTCTC CTGAAAGTGC TGATAAGAGG 
361 TCGTTTCTCA AAAGGCCCAA ATCTCAGGTG TCCGAGGAAG AAGGCAAAGA AGTAGAGTCA 
AGCAAAGAGT TTTCCGGGTT TAGAGTCCAC AGGCTCCTTC TTCCGTTTCT TCATCTCAGT 
421 GATAAAGAAA 
CTATTTCTTT 








481 GAGATCATTT TAAAGGCCCC AATTGCAGCT CCTGAACCGG AACTCAAAAC AGACCCATCT 
CTCTAGTAAA ATTTCCGGGG TTAACGTCGA GGACTTGGCC TTGAGTTTTG TCTGGGTAGA 
541 TTGGATCTTC ATTCATTAAG CAGTGCAGAA ACACAGCCTC ACCATTACAA TTAAGAATTA 
AACCTAGAAG TAAGTAATTC GTCACGTCTT TGTGTCGGAG TGGTAATGTT AATTCTTAAT 
Motif V 
601 TTTTTAGAGT CTTCTTATTT CTGAAGCATG TGAATATTAT CTCGATCGTT AAAAGTCCTG 











721 AGTGCTCCAA AATAGAAGTA AAAGAAGAAA GCCCTCAATC AAAAGCAGAA ACAGAATTAA 
TCACGAGGTT TTATCTTCAT TTTCTTCTTT CGGGAGTTAG TTTTCGTCTT TGTCTTAATT 
781 AAGCTTCCCA AAAACCAATC AGAAAACACA GGAACATGCA CTGCAAGGTT TCTTTGTTGG 
TTCGAAGGGT TTTTGGTTAG TCTTTTGTGT CCTTGTACGT GACGTTCCAA AGAAACAACC 
841 ATGACACAGT TTATGAATGT GTTGTGGAG 
TACTGTGTCA AATACTTACA CAACACCTC 
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RESULTS and DISCUSSION 
Expression of Motif I during Erythroid Cell Maturation. In 
order to assess the pattern of motif I expression in mRNA of 
erythroid cells during maturation, I performed RNase 
protection assays and Northern blot analyses on RNA samples 
collected from MEL cells at 0, 24, and 48 hrs after induction 
with DMSO. An RNase protection assay allows a specific 
comparison between a cell's RNA and a labeled antisense RNA 
probe. If the probe does not base pair precisely to the RNA, 
extra tails or loops not protected by RNA hybridization will 
be excised by RNase digestion. Therefore, probes designed to 
span motif I can generate distinct protected fragments when 
hybridized to mRNAs with or without motif I. 
Northern blot analysis also identifies homologous RNA 
species in a cell's mRNA. This method detects sequences 
complementary to a labeled antisense probe via hybridization 
with poly (A) + RNA bound to a filter. These probes are 
derived from sequences present within motif I, and thus will 
bind only to RNA that contains motif I. 
Both of these studies produced similar results in that 
neither showed specific hybridization to the antisense motif 
I probes. Possible explanations include lack of homology 
between mouse (RNA) and human (probes) sequences or inadequate 
amounts of RNA containing motif I, especially in the early 
stages of induction. The RNase protection assay is quite 
sensitive but is susceptible to excessive probe digestion if 
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the probe and RNA are insufficiently homologous. The Northern 
blot is capable of detecting modestly homologous RNAs but is 
not especially sensitive. Therefore, the most likely 
explanation of these disappointing results is that the RNase 
protection assay failed to work because of inadequate 
homology; the Northern blot assay is more tolerant of partial 
homology but is far less sensitive. 
On the basis of these findings, Dr. Lily Lou subsequently 
elucidated the pattern of motif I expression during erythroid 
cell maturation using PCR. This technique specifically 
replicates a particular segment of DNA by flanking the 
fragment with oligonucleotide primers and repeatedly 
denaturing, annealing, and extending the primers. These 
primers hybridize to opposite strands of the target sequence 
and are oriented so that DNA synthesis by a heat-stable 
polymerase proceeds across the region between the primers. 
Since the extension products themselves are also complementary 
to and capable of binding primers, successive cycles of 
amplification result in an exponential accumulation of the 
specific target fragment. By amplifying the region of mRNA 
containing motif I, Dr. Lou showed that barely detectable 
amounts of motif I are present in the uninduced cells. An 
appreciable increase in motif I expression occurred between 86 
and 110 hours, and a decline in expression began after 122 
hours of induction. The induction of motif I takes place at 
least 48 hours after globin induction (Figure 7). 
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Expression of Motifs IV and V in Non-Erythroid Hematopoietic 
Cells. PCR amplifications of sequences spanning motif IV and 
motif V were targeted by using 5' and 3' flanking 
oligonucleotides for each motif. The expected products 
obtained by amplifying cDNA templates that include or exclude 
motif IV were 96 bp and 79 bp, respectively and 258 bp and 178 
bp, respectively for motif V. Use of the 5' motif IV primer 
and the 3' motif V primer allows analysis of both motifs as 
they occur on a single template; the expected products in this 
case are 626 bp (+IV, +V), 546 bp (+IV, -V), 609 bp (-IV, +V), 
and 529 bp (-IV, -V). Amplification of cDNA generated from 
the non-erythroid cell lines HL60, KG-1, KG-la, MOLT 4, CCRF- 
CEM, and HUT 78 was performed. 
Analysis of the PCR products by ethidium bromide staining 
of agarose gels generally reveals only the most prominent 
products, as shown in Figure 8. In this case, the vast 
majority of RNA species in non-erythroid cells exhibit only a 
single band, 178 bp in length, when amplified with primers 
flanking motif V. These results suggest that the bulk of 
protein 4.1 mRNA present in the cells lacks motif V. When 
analyzed with primers flanking motif IV, these RNAs generated 
more complex results (Figure 9). Two bands, 96 bp and 79 bp, 
of roughly equal intensity are seen in most of the cell lines. 
These bands correspond well to the predicted sizes for RNAs 
containing and lacking motif IV. Analysis with primers 
yielding a PCR product that spans both motifs (Figure 10) 
showed only a single band, 546 bp, consistent with absence of 
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motif V and presence or absence of motif IV. (Note that the 
17 bp difference between products containing and lacking motif 
IV cannot be resolved on this gel due to the large size of the 
fragments). 
The PCR products were further analyzed by Southern blot 
analysis using oligonucleotides complementary to each motif 
(Figure 5B). This technique will detect minor species as well 
as the more predominant products detected by ethidium bromide 
staining. However, neither method can be utilized for 
quantitative assessment of relative amounts of individual 
motifs. When the products amplified by primers flanking motif 
V were hybridized to a probe complementary to sequences within 
motif V, products containing motif V could then be visualized 
(Figure 11). These migrated to a position corresponding to a 
size roughly 80 bp larger than the ethidium bromide stained 
bands, which, of course, did not hybridize to the probe 
because they lack motif V. Similarly, Southern blot analysis 
of products generated by motif IV amplification (Figure 12) 
showed a predominant band at the size expected for retention 
of motif IV as well as some minor bands of higher molecular 
weight, the identity of which remain unknown. Finally, Figure 
13 shows that at least a portion of the products spanning both 
motifs contain motif IV. This experiment suggests that at 
least some transcripts lacking motif V contain motif IV, but 
that no transcripts containing motif V also contain motif IV. 
Confirmation of this preliminary finding will require further 
Southern analysis with motif V probes. It is essential to 
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recall that the products containing motif V represent only a 
small fraction of the RNA (Figures 8 vs. 11). Therefore, the 
apparent absence of motif IV signal for the band labeled +V in 
Figure 13 could also be a sensitivity problem. 
Although these studies require additional data to permit 
firm conclusions, my results strongly suggest that mRNA 
species capable of encoding the higher molecular weight 
isoform (i.e. retaining motif IV and lacking motif V, c.f. 
Figures 10 and 13) constitute a significant amount of the 
total RNA made in non-erythroid blood cells. This expression 
is achieved by elimination of motif V from the vast majority 
of species, while motif IV is retained or eliminated in 
roughly equal numbers of the mature mRNAs. Thus, motifs IV 
and V in these cells are probably not spliced in concert. 
(However, as discussed for Figure 13, it is possible that 
motif IV is selectively absent from mRNA retaining motif V.) 
This suggests that the predominant regulation of high vs. low 
molecular weight isoform production occurs via splicing of 
motif IV. 
Expression of Motifs IV and V during Erythroid Cell 
Maturation. With the successful amplification of motif I in 
MEL cells, it seemed reasonable to expect similar results from 
investigation of motifs IV and V during MEL cell maturation. 
PCR amplification of these motifs with the same primers used 
in non-erythroid cells (Figure 6B) was attempted using cDNA 
templates generated from the mRNA of MEL cells collected at 0, 
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27, 48, 60, 73, 86, 98, 110, 122, 167, and 186 hours after 
induction. No products were seen. These results may again be 
attributable to inadequate homology between mouse and human 
sequences in the region of mRNA where motifs IV and V are 
located. However, abundant evidence in the PCR literature 
shows that successful amplification using any given primer 
pair depends on far more than homology alone and that other 
factors (GC content, secondary structure) may be responsible. 
This left two choices: (1) clone and sequence the mouse 
protein 4.1 gene so that perfectly homologous primers could be 
obtained, or (2) design alternative primers with different 
parameters in the hope that their homology to mouse sequences 
or their possession of dissimilar structural would yield more 
favorable results. I chose to pursue the latter option, 
because insufficient time was available to complete the 
former. The new primers pairs were selected on the basis of 
equal length, 50% GC content, identical melting temperature, 
absence of 3 or more G or C bases at the 3' end, no 
significant secondary structure, and, where possible, no runs 
of 3 bases. Although I have not yet tested these primers 




Figure 7: Ethidium bromide stained agarose gels showing 
induction of motif I and globin during MEL cell maturation. 
A. Terminal maturation of MEL cells was induced with DMSO. 
PCR analysis of RNA at time points during induction identifies 
the beginning of motif I expression. Expected sizes of 
products containing and lacking motif I are 468 bp and 405 bp, 
respectively. For unknown reasons, the mouse fragment without 
motif I migrates more rapidly than the comparable human 
fragment. 
B. Similar PCR analysis of globin RNA expression shows that 
motif I is expressed later than globin by nearly 48 hours. 
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Figure 8: Analysis of PCR products on ethidium bromide 
stained agarose gel. Expected sizes of products containing 
and lacking motif V are 258 bp and 178 bp, respectively. The 
fragments observed here are between 118 bp and 194 bp, a size 
consistent with absence of motif V. 
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Figure 9: Analysis of PCR products on ethidium bromide 
stained agarose gel. Expected sizes of products containing 
and lacking motif IV are 96 bp and 79 bp, respectively. The 
fragments observed here are of two sizes: (1) between 72 bp 
and 118 bp and (2) roughly equal to 72 bp. These bands 
indicate that motif IV is present in some products and absent 
in others, often within a single cell line. 
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Figure 10: Analysis of PCR products on ethidium bromide 
stained agarose gel. Expected sizes of products containing 
motif V are 626 bp and 609 bp, while those lacking motif V are 
546 bp and 529 bp. Since the fragments observed here all fall 
below the 603 bp marker, it can be concluded that they lack 
motif V. Presence or absence of motif IV cannot be determined 
from this gel, as a 17 bp difference is indistinguishable in 
fragments of this size. 
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Figure 11: Southern blot analysis of PCR products. Predicted 
sizes of products containing and lacking motif V are 
indicated. The lower arrow corrsponds to the band seen on the 
ethidium bromide stained agarose gel. While the ethidium 
bromide stained agarose gel demonstrated that a majority of 
fragments lack motif V, hybridization with a motif V-specific 
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Figure 12: Southern blot analysis of PCR products. Predicted 
sizes of products containing and lacking motif IV are 
indicated. The arrows correspond to the two major bands seen 
on the ethidium bromide stained agarose gel. Hybridization 
with a motif IV-specific probe confirms that the larger band 




Figure 13: Southern blot analysis of PCR products. Predicted 
sizes of products containing and lacking motif V are 
indicated. Presence of motif IV is determined by 
hybridization to a motif IV-specific probe. On the basis of 
these data, it may be concluded that the products visualized 
on this blot contain motif IV and lack motif V. 
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SUMMARY and CONCLUSIONS 
Protein 4.1 is a family of related cytoskeletal protein 
isoforms present in many cell types. These isoforms differ at 
specific points, designated motifs I-VIII, which are 
alternatively spliced nucleotide segments within protein 4.1 
mRNA transcripts. Motif I is expressed in a tissue-specific 
manner, being found only in erythroid cells. In addition, a 
high molecular weight variant of protein 4.1, which localizes 
to nuclear as well as cytoplasmic structures of non-erythroid 
cells, is generated by concerted splicing of the two upstream 
motifs, IV and V. 
The work presented in this thesis compared the pattern of 
mRNA splicing of motifs IV and V in erythroid and non- 
erythroid cells and investigated the timing of splicing events 
during erythroid maturation. PCR amplification of regions of 
mRNA spanning motifs IV and V in non-erythroid cells suggest 
that a substantial portion of transcripts encode the high 
molecular weight variant. Southern blotting revealed that 
transcripts for low molecular weight variants were also 
generated, and that their production usually occurs via motif 
IV deletion, rather than motif V insertion. These results 
provide the first indication of the mechanism by which cells 
regulate the production of high and low molecular weight 
protein 4.1 isoforms. 
This research also addressed the developmental regulation 
of splicing events during erythroid maturation. On the basis 
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of my early findings from RNase protection assays and Northern 
blotting, another investigator employed PCR amplification to 
demonstrate the induction of motif I splicing between 86 and 
110 hours after induction of MEL cells. Motif I induction 
follows that of the major erythrocyte protein, globin. 
Similar PCR amplification studies of motif IV and V expression 
during erythroid maturation have been unsuccessful. 
My findings strongly imply that subsequent efforts to 
study the regulation of production of the 135 kD protein 4.1 
isoform should be concentrated on the sequences surrounding 
motif IV. I have provided preliminary but highly suggestive 
evidence that the decision to include or exclude this motif 
from mature mRNA is the major determinant controlling this 
isoform. Therefore, this region is most likely to yield the 
cis-acting signals or the binding sites of trans-acting 
factors that regulate alternative splicing and production of 
this large isoform. These can be dissected by in vitro site- 
directed mutagenesis. The tissue-specificity and 
developmental behavior of the protein 4.1 mRNA precursor 
provides a unique opportunity for study of the control of 
alternative mRNA splicing in a multi-functional tissue- 
specific protein family. My results suggest that control of 
this family may reside in only a selected subset of the 
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